Right now, Americans are watching the Great 2026 Gold Reset unfold in real time.
President Trump is utilizing the Gold Reserve Act, U.S. Code Title 31, Section 5117, to explore a historic revaluation of America's reserves from $42 to current market prices. As gold continues its explosive rally, that's a move that could send shockwaves through every portfolio in America.
And that's just the beginning.
The administration has launched "Project Vault," a $12 billion strategic critical minerals reserve to shield American industry and ensure total resource sovereignty. Insiders say this is just the beginning.
Strategic tariffs are dismantling "paper-based" globalist controls and triggering a manufacturing renaissance, and gold hasn't stopped climbing. The window to get in is narrowing fast.
The "Gold Reset" is now a central pillar of the America First era, signaling a return to tangible value and what analysts are calling a once-in-a-lifetime vertical ascent for precious metals.
The Americans who move first stand to benefit most.
Genesis Gold Group, a faith-focused precious metals company with 50+ years of combined expertise, has created the FREE 2026 Gold Reset Guide to help you understand what's unfolding and how to take action.
Protect Your Financial Future: Claim Your FREE 2026 Gold Reset Guide
Whether you're looking to protect your IRA or 401(k) with a Precious Metals IRA or invest directly in physical gold and silver, Genesis Gold Group combines biblical stewardship principles with strategic expertise to help your hard-earned wealth thrive during this historic period.
Don't just take our word for it:
"We compared a number of Gold IRA companies and went with Genesis Gold Group. Great industry knowledge and their staff were very patient with us during the process. IRA. Their prices and expertise made it an easy decision to invest with them."
- J. Schott, Denver, CO
Secure Your Family's Prosperity: Download Your FREE 2026 Gold Reset Guide Now
Just Buy It? Barclays Thinks Nike Is Ready to Run
By Jeffrey Neal Johnson. First Published: 3/12/2026.
Key Points
- NIKE's strategic reset in North America is proving successful, with a revitalized wholesale channel signaling renewed confidence from retail partners.
- The company's innovation pipeline is accelerating, with exciting new footwear and apparel platforms set to fuel the next phase of its market recovery.
- Following a period of underperformance, Wall Street analysts now see significant upside potential in the stock as the company's turnaround gains traction.
- Special Report: The Biggest IPO Ever: Claim Your Stake Today
For months, investors have watched Nike, Inc. (NYSE: NKE), a titan of the consumer discretionary sector, struggle to find its footing. The stock's persistent underperformance has tested the patience of even its most loyal shareholders. But a recent catalyst sent a clear signal: a decisive Overweight upgrade from Barclays has injected fresh optimism, suggesting the tide may finally be turning. That external validation aligns with CEO Elliott Hill's message that Nike is in the middle innings of a comeback — executing a strategic recovery rather than merely starting to address its problems.
The Comeback's Home-Field Advantage
Before a global comeback can take hold, a company must first win at home. For Nike, the latest financial results from its North American segment provide compelling evidence that the turnaround is real. The region posted 9% revenue growth in the second quarter, driven largely by a 24% increase in wholesale.
Elon's Private AI Empire: The Backdoor Under $100 (Ad)
Elon Musk's AI Everywhere project isn't inside Tesla—it's a private venture with a global network of 150+ facilities embedding autonomous AI into devices everywhere, and Musk believes this could propel Tesla to become the most valuable company ever, worth more than Apple, Microsoft, Nvidia, Amazon, and Google combined. Private ventures like this are usually locked for elites, but I've found a legitimate brokerage backdoor under $100 with no special requirements, just a regular account, and this private play follows the same playbook as PayPal, SpaceX, Tesla, and xAI using Tesla's proven autonomous AI copy-pasted across the world.
See the 3 steps to profit before the summer regulatory shiftThat wholesale strength is a crucial indicator. It reflects a strategic pivot away from an overly aggressive direct-to-consumer focus and toward re-engaging key retail partners. By doing so, Nike is better managing inventory and reaching a broader customer base.
Strong wholesale growth also suggests the painful inventory glut has largely cleared. Retail partners are not only selling through old product but are now placing larger orders for new merchandise. Management has pointed to an improving order book for the upcoming spring and summer seasons, reinforcing this forward-looking momentum.
Operationally, fewer excess goods mean fewer promotions and stronger full-price sell-through — the primary ingredients for sustainable revenue growth and a recovery in gross margins.
From Inventory Cleanup to Innovation Rollout
With retail channels cleared and partners restocked, the focus turns to what will drive the next growth phase. Nike's Sport Offense framework is designed to accelerate a steady flow of athlete-centered innovation to the market, supplying partners with high-margin products that helped build the brand.
The initial results are already compelling:
- Running on All Cylinders: Performance running has grown by more than 20% for two consecutive quarters, signaling market-share gains driven by consistent product newness. Shoes like the Structure 26, a stability model offering enhanced support, are resonating.
- Apparel's Next Advance: Nike plans to debut its AeroFit platform, described as "air conditioning for the body," in national team kits — bringing tangible performance tech to a massive World Cup audience.
- Basketball Bounces Back: Consumer excitement is returning to basketball, with strong sell-through for signature shoes and positive reception for launches like the GT Future, which is driving traffic to retailers.
Perhaps the most definitive proof of renewed product strength is retailer bookings: World Cup bookings are up nearly 40% versus the 2022 event, a strong vote of confidence in the new lineup. The takeaway for investors is clear — Nike is shifting from selling more to selling better, a strategy that supports margin recovery.
Taking the Winning Formula Global
North America provides a blueprint, but investors remain focused on headwinds elsewhere, particularly Greater China and the Converse brand. These challenges should be seen as the next phase of a proven turnaround. Management has acknowledged Greater China's weakness, where revenue fell 17%, and responded with an actionable plan: a revised leadership structure reporting directly to the CEO for faster decisions, strategic investments in key-city retail, and a pivot back to innovation-led, premium positioning rather than competing on price.
Margin pressure has been a central concern. CFO Matthew Friend noted that, excluding the external impact of tariffs, Nike's underlying gross margins are already expanding. That suggests the core business is healing and profitability is improving as the company executes its plan.
A Discount on a Blue-Chip Rebound
Valuation completes the investment picture. Nike's stock price has traded down roughly 12% year-to-date and about 25% over the past year. Much of this pullback reflects the now-addressed inventory issues and known China challenges, creating what many analysts view as an attractive entry point.
The Wall Street consensus price target is $74.90, implying more than 30% upside from current levels. With a forward price-to-earnings ratio of 27.33, the stock is priced for a meaningful earnings rebound.
The argument: the market has largely priced in the negatives from the Converse reset and the multi-quarter China recovery. As North America's recovery continues and international segments show signs of stabilization, the stock could re-rate higher as investors begin to price in the turnaround's success.
Lacing Up for the Next Leg of Growth
The Barclays upgrade appears to be more than a headline — it's external validation of progress that is visible in the numbers. North America offers proof of concept, the innovation pipeline is supplying fuel, and the stock's current valuation may offer an opportunity.
While the global turnaround remains in the middle innings, the most critical phase — the reset of its core market — is largely complete. The next major checkpoint will be Nike's third-quarter earnings report on March 31, where continued margin improvement and any signs of stabilization in China will be key indicators that the comeback is hitting its stride.
Megatrends Still Matter: 3 Growth Stocks for the Next 10 Years
Submitted by Chris Markoch. Date Posted: 3/12/2026.
Key Points
- Eli Lilly is capitalizing on multiple healthcare megatrends, including blockbuster GLP-1 drugs, oncology innovation, and Alzheimer’s research.
- Vertiv sits at the center of the AI infrastructure boom, providing power and cooling systems for energy-intensive data centers.
- First Solar benefits from the long-term shift toward clean energy, supported by domestic manufacturing advantages and strong demand from hyperscalers.
- Special Report: The Biggest IPO Ever: Claim Your Stake Today
A megatrend is a long-term shift that affects many aspects of society and shapes the future over decades. The internet — and more specifically, the smartphone — are good examples.
Investing in technology stocks such as Amazon.com Inc. (NASDAQ: AMZN), Microsoft Corp. (NASDAQ: MSFT) and Apple Inc. (NASDAQ: AAPL) during that era would have been contrarian moves that paid off handsomely. In fact, those companies continue to reward shareholders as the underlying trends persist.
Elon's Private AI Empire: The Backdoor Under $100 (Ad)
Elon Musk's AI Everywhere project isn't inside Tesla—it's a private venture with a global network of 150+ facilities embedding autonomous AI into devices everywhere, and Musk believes this could propel Tesla to become the most valuable company ever, worth more than Apple, Microsoft, Nvidia, Amazon, and Google combined. Private ventures like this are usually locked for elites, but I've found a legitimate brokerage backdoor under $100 with no special requirements, just a regular account, and this private play follows the same playbook as PayPal, SpaceX, Tesla, and xAI using Tesla's proven autonomous AI copy-pasted across the world.
See the 3 steps to profit before the summer regulatory shiftThat raises the question: which megatrends today could reward investors over the next 20 to 30 years? Artificial intelligence (AI) will often top the list, but it is far from the only one.
Other durable trends include an aging global population that is increasing demand for breakthrough medical treatments and an evolving energy story focused on how we generate, manage and deliver power. The three companies below sit at the intersection of these megatrends and could compound for patient, long-term investors.
A Diversified Play on Healthcare Megatrends
It's reasonable to expect Eli Lilly & Co. (NYSE: LLY) to be on this list because of its leadership in GLP-1 drugs. Mounjaro and Zepbound are market-leading therapies for type 2 diabetes and obesity, respectively — two conditions that materially drive healthcare costs.
In its most recent quarter, Mounjaro generated $7.4 billion in global sales — more than a third of total revenue of $19.29 billion. Zepbound contributed roughly $4.5 billion. Both drugs still address large markets, and Lilly is advancing an oral GLP-1 candidate, orforglipron, currently in Phase 3 trials.
The long-term case for Lilly extends beyond GLP-1s. The company also has meaningful efforts in oncology and Alzheimer's disease, with a deep pipeline of candidates. Its strong balance sheet reduces dependence on any single trial or product.
Over the past five years, LLY has delivered price appreciation of over 380%. Including dividends, total return exceeds 400% for the same period. Some investors may view that run-up warily, but Lilly's exposure to multiple healthcare megatrends makes it an attractive option for buy-and-hold investors seeking long-term growth.
The Backbone of the AI Data Center Boom
No megatrend stock list for the next decade would be complete without at least one AI-related company. That brings us to Vertiv Holdings Inc. (NYSE: VRT).
AI models demand massive, continuous power, which is accelerating data center construction. Those facilities require sophisticated power management and cooling systems — Vertiv's core products and services.
That dynamic supported strong fourth-quarter and full-year growth in 2025, with momentum expected to continue into 2026 and likely beyond.
VRT has been publicly traded for five years, and shareholders have seen share-price gains of more than 1,200% in that span. The company has also initiated and grown a dividend over the last two years, adding an income component to total return.
Clean Energy Infrastructure for a Power-Hungry World
The energy megatrend is among the most durable themes for coming decades. Electrification of transportation, the growth of AI-driven data centers, and global efforts to decarbonize power grids are creating large and growing demand for clean electricity generation. First Solar Inc. (NASDAQ: FSLR) is well positioned to benefit.
Unlike many competitors, First Solar manufactures panels domestically using its proprietary thin-film cadmium telluride (CdTe) technology. That U.S. manufacturing footprint is a structural advantage in a policy environment that favors American-made clean energy products.
Domestic production also reduces exposure to some supply-chain vulnerabilities and tariff risks that affect companies relying on overseas manufacturing.
Demand for utility-scale solar continues to grow, in part driven by the same data center buildout supporting Vertiv. Hyperscalers and other large companies have committed to substantial renewable energy purchases. First Solar's order backlog extends years into the future, providing a level of revenue visibility that is uncommon in the sector.
After a challenging stretch for solar stocks over the past three years, FSLR is up more than 150% over five years. Analysts' consensus price target sits near $249, implying upside of about 25% from current levels.
Each of these companies—Eli Lilly, Vertiv and First Solar—offers exposure to durable, multi-decade trends. For investors with a long time horizon and the patience to ride cycles, they represent distinct ways to participate in healthcare innovation, AI infrastructure and the transition to cleaner power.
This email content is a paid sponsorship sent on behalf of Genesis Gold Group, a third-party advertiser of DividendStocks.com and MarketBeat.
If you have questions or concerns about your newsletter, don't hesitate to contact our South Dakota based support team at contact@marketbeat.com.
If you no longer wish to receive email from DividendStocks.com, you can unsubscribe.
© 2006-2026 MarketBeat Media, LLC. All rights reserved.
345 North Reid Place, Suite 620, Sioux Falls, South Dakota 57103. U.S.A..